Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Parthena Martin
Institution:
Zogenix (United States)
Observed institution:
Zogenix (United States)
ORCID:
0000-0002-1169-0495
Observed ORCID:
0000-0002-1169-0495
OpenAlex ID:
A5001772863
Fenfluramine acts as a positive modulator of sigma-1 receptors
2020
·
Parthena Martin
, Peter A.M. de Witte
, et al.
·
Epilepsy & Behavior
·
105
PDF
An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies
2021
·
Parthena Martin
, Thadd Reeder
, et al.
·
International Journal of Molecular Sciences
·
65
PDF
In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
2022
·
Parthena Martin
, Maciej Czerwiński
, et al.
·
Pharmacology Research & Perspectives
·
25
In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions
2022
·
Parthena Martin
, Maciej Czerwiński
, et al.
·
Pharmacology Research & Perspectives
·
21
PDF
Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo
2022
·
Parthena Martin
, Tangui Maurice
, et al.
·
Epilepsy & Behavior
·
21
PDF
663. An Examination of the Mechanism of Action of Fenfluramine in Dravet Syndrome: A Look beyond Serotonin
2017
·
Parthena Martin
, Arnold Gammaitoni
, et al.
·
Biological Psychiatry
·
4
Project Management and the Role of a Study Director
2014
·
Debra Kirchner
, Parthena Martin
, et al.
·
Wiley eBooks
Show more works
View as search
Works count:
7
Citation count:
241
H-index:
5
I10-index:
5
Year
Topic
Type
